Dear S.R.: Tirzepatide (Zepbound), like semaglutide, is a prescription medication originally used for diabetes but now ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...

Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced ...